Search

Your search keyword '"Toprak, Umut H."' showing total 44 results

Search Constraints

Start Over You searched for: Author "Toprak, Umut H." Remove constraint Author: "Toprak, Umut H." Database Unpaywall Remove constraint Database: Unpaywall
44 results on '"Toprak, Umut H."'

Search Results

1. Altered enhancer-promoter interaction leads toMNX1expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)

2. S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q

3. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

4. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

5. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

6. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

7. Supplementary Figure S3 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

8. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

9. Supplementary Figure S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

10. Supplementary Table S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

11. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

12. Supplementary Table S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

13. Supplementary Figure S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

14. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

15. Supplementary Figure S3 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

16. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

17. Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking

18. Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia

19. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas

20. T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

21. Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities

22. Loss of p16INK4a in neuroblastoma cells induces shift to an immature state with mesenchymal characteristics and increases sensitivity to EGFR inhibitors

23. FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome

24. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma

25. Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

26. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome

27. Accurate and efficient detection of gene fusions from RNA sequencing data

28. Super enhancers define regulatory subtypes and cell identity in neuroblastoma

29. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone

30. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma

31. Globally altered epigenetic landscape and lagging osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone

32. Reconstruction of rearranged T‐cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T‐cell prolymphocytic leukemia

33. Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of “MYC-negative” Burkitt lymphoma

34. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma

35. IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

36. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer

37. NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

38. Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

39. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature

40. Resolving drug effects in patient-derived cancer cells links organoid responses to genome alterations

42. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

44. Modulation of the Chromatin Phosphoproteome by the Haspin Protein Kinase

Catalog

Books, media, physical & digital resources